BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park S, Kim J, Chun J, Han K, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study. J Clin Med. 2019;8. [PMID: 31398905 DOI: 10.3390/jcm8081191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
2 Szandruk-bender M, Wiatrak B, Szeląg A. The Risk of Developing Alzheimer’s Disease and Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis. JCM 2022;11:3704. [DOI: 10.3390/jcm11133704] [Reference Citation Analysis]
3 Cabezudo D, Baekelandt V, Lobbestael E. Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation. Front Neurosci 2020;14:376. [PMID: 32410948 DOI: 10.3389/fnins.2020.00376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
4 Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020;134:104700. [PMID: 31809788 DOI: 10.1016/j.nbd.2019.104700] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
5 Liu B, Sjölander A, Pedersen NL, Ludvigsson JF, Chen H, Fang F, Wirdefeldt K. Irritable bowel syndrome and Parkinson's disease risk: register-based studies. NPJ Parkinsons Dis 2021;7:5. [PMID: 33402695 DOI: 10.1038/s41531-020-00145-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shannon KM. Gut-Derived Sterile Inflammation and Parkinson's Disease. Front Neurol 2022;13:831090. [DOI: 10.3389/fneur.2022.831090] [Reference Citation Analysis]
7 Guo M, Ji X, Liu J. Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease. Front Aging Neurosci 2022;14:919343. [DOI: 10.3389/fnagi.2022.919343] [Reference Citation Analysis]
8 Drobny A, Ngo PA, Neurath MF, Zunke F, López-Posadas R. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease. Front Med (Lausanne) 2021;8:655123. [PMID: 34368179 DOI: 10.3389/fmed.2021.655123] [Reference Citation Analysis]
9 Talley S, Valiauga R, Anderson L, Cannon AR, Choudhry MA, Campbell EM. DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod. J Neuroinflammation 2021;18:263. [PMID: 34758843 DOI: 10.1186/s12974-021-02317-6] [Reference Citation Analysis]
10 Liu B, Wanders A, Wirdefeldt K, Sjölander A, Sachs MC, Eberhardson M, Ye W, Ekbom A, Olén O, Ludvigsson JF. Vagotomy and subsequent risk of inflammatory bowel disease: a nationwide register-based matched cohort study. Aliment Pharmacol Ther 2020;51:1022-30. [PMID: 32319125 DOI: 10.1111/apt.15715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Kang EA, Chun J, Kim JH, Han K, Soh H, Park S, Hong SW, Moon JM, Lee J, Lee HJ, Park JB, Im JP, Kim JS. Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study. World J Gastroenterol 2020; 26(37): 5661-5672 [PMID: 33088159 DOI: 10.3748/wjg.v26.i37.5661] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zheng H, Qian X, Tian W, Cao L. Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data. Brain Sci 2022;12:774. [PMID: 35741659 DOI: 10.3390/brainsci12060774] [Reference Citation Analysis]
13 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
14 Herrick MK, Tansey MG. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease? NPJ Parkinsons Dis 2021;7:26. [PMID: 33750819 DOI: 10.1038/s41531-021-00170-1] [Reference Citation Analysis]
15 Noh H, Jang J, Kwon S, Cho SY, Jung WS, Moon SK, Park JM, Ko CN, Kim H, Park SU. The Impact of Korean Medicine Treatment on the Incidence of Parkinson's Disease in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study in South Korea. J Clin Med 2020;9:E2422. [PMID: 32731605 DOI: 10.3390/jcm9082422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
17 Tsafaras G, Baekelandt V. The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases. Neurobiol Dis 2022;172:105806. [PMID: 35781002 DOI: 10.1016/j.nbd.2022.105806] [Reference Citation Analysis]
18 Cannon T, Sinha A, Trudeau LE, Maurice CF, Gruenheid S. Characterization of the intestinal microbiota during Citrobacter rodentium infection in a mouse model of infection-triggered Parkinson's disease. Gut Microbes 2020;12:1-11. [PMID: 33064969 DOI: 10.1080/19490976.2020.1830694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Guo X, Chong L, Zhang X, Li R. Immunosuppressants contribute to a reduced risk of Parkinson's disease in rheumatoid arthritis. Int J Epidemiol 2022:dyac085. [PMID: 35472175 DOI: 10.1093/ije/dyac085] [Reference Citation Analysis]
20 Wenzel TJ, Haskey N, Kwong E, Greuel BK, Gates EJ, Gibson DL, Klegeris A. Dietary fats modulate neuroinflammation in mucin 2 knock out mice model of spontaneous colitis. Biochim Biophys Acta Mol Basis Dis 2022;1868:166336. [PMID: 34973372 DOI: 10.1016/j.bbadis.2021.166336] [Reference Citation Analysis]
21 Wang YC, Huang AP, Yuan SP, Huang CY, Wu CC, Poly TN, Atique S, Kung WM. Association between Anemia and Risk of Parkinson Disease. Behav Neurol 2021;2021:8360627. [PMID: 34306250 DOI: 10.1155/2021/8360627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Dumitrescu L, Marta D, Dănău A, Lefter A, Tulbă D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease. Front Neurosci 2021;15:689723. [PMID: 34220443 DOI: 10.3389/fnins.2021.689723] [Reference Citation Analysis]
23 Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Front Neurosci 2022;16:836605. [DOI: 10.3389/fnins.2022.836605] [Reference Citation Analysis]
24 Pap D, Veres-Székely A, Szebeni B, Vannay Á. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases. Int J Mol Sci 2022;23:6626. [PMID: 35743072 DOI: 10.3390/ijms23126626] [Reference Citation Analysis]
25 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]